Ditchcarbon
  • Contact
  1. Organizations
  2. Bracco Diagnostics Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Bracco Diagnostics Inc. Sustainability Profile

Company website

Bracco Diagnostics Inc., a prominent player in the medical imaging industry, is headquartered in the United States. Founded in 1927, the company has established itself as a leader in the development and production of contrast agents and imaging solutions, serving healthcare professionals across North America and beyond. Bracco's core offerings include a range of innovative contrast media for various imaging modalities, such as MRI and CT scans, which enhance diagnostic accuracy and patient care. Renowned for their commitment to quality and safety, Bracco's products are designed to meet the evolving needs of the medical community. With a strong market position, Bracco Diagnostics has achieved significant milestones, including numerous regulatory approvals and partnerships that underscore its reputation for excellence in the field of diagnostic imaging.

DitchCarbon Score

How does Bracco Diagnostics Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

39

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Bracco Diagnostics Inc.'s score of 39 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

64%

Let us know if this data was useful to you

Bracco Diagnostics Inc.'s reported carbon emissions

Inherited from Bracco S.p.A.

Bracco Diagnostics Inc., headquartered in the US, currently does not report specific carbon emissions data for the latest year, as indicated by the absence of emissions figures. The company is a current subsidiary of Bracco S.p.A., which may influence its climate commitments and reporting practices. As of now, Bracco Diagnostics Inc. has not established any documented reduction targets or climate pledges. This lack of specific initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of direct emissions data, it is essential to consider the broader context of the industry, where many organisations are increasingly focusing on sustainability and carbon footprint reduction. Bracco Diagnostics Inc. may benefit from aligning with industry standards and practices to enhance its environmental performance in the future. Overall, while specific emissions data and reduction targets are not available, the company's affiliation with Bracco S.p.A. may provide a framework for future climate commitments and initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
49,469,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
41,475,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-
-

How Carbon Intensive is Bracco Diagnostics Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bracco Diagnostics Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Bracco Diagnostics Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Bracco Diagnostics Inc. is in US, which has a low grid carbon intensity relative to other regions.

Bracco Diagnostics Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Bracco Diagnostics Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Bracco Diagnostics Inc.'s Emissions with Industry Peers

Varian

US
•
Fabricated metal products, except machinery and equipment (28)
Updated 3 days ago

Canon Medical Systems Corporation

JP
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Hitachi Healthcare Manufacturing, Ltd.

JP
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 21 days ago

Jubilant Pharma Limited

SG
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Mindray

CN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Carestream Health

US
•
Health and social work services (85)
Updated 15 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy